Table 1 Characteristics of RAM patients from PUMCH
Observation (n = 5) | Laser Photocoagulation (n = 4) | Anti-VEGF (n = 5) | O. vs L.a | O. vs A.a | L. vs A.a | |
|---|---|---|---|---|---|---|
p | p | p | ||||
Age(y) | 68.20 ± 6.38 | 71.50 ± 6.46 | 75.20 ± 6.22 | 0.454 | 0.109 | 0.403 |
Sex(F) | 2 | 4 | 5 | 0.501 | 0.501 | 1.000 |
Eye (OS) | 5 | 2 | 2 | 0.501 | 0.501 | 1.000 |
Hypertension | 4 | 2 | 2 | 1.000 | 1.000 | 1.000 |
Diabetes | 2 | 0 | 2 | 1.000 | 1.000 | 1.000 |
Complication (Exudative) | 2 | 4 | 1 | 0.501 | 1.000 | 0.143 |
No past treatment | 4 | 4 | 5 | 1.000 | 1.000 | 1.000 |
Preretinal hemorrhage | 1 | 0 | 4 | 1.000 | 0.618 | 0.143 |
Macular hard exudates | 2 | 2 | 0 | 1.000 | 1.000 | 0.501 |
Distance from fovea | 3098.80 ± 1712.84 | 2690.75 ± 874.44 | 1541.4 ± 1202.00 | 0.658 | 0.094 | 0.228 |
Duration of symptoms | 3.60 ± 2.19 | 1.50 ± 0.58 | 2.20 ± 2.16 | 0.125 | 0.265 | 0.591 |
Interval(m) | 7.40 ± 5.13 | 2.75 ± 1.50 | 5.20 ± 3.96 | 0.110 | 0.401 | 0.379 |
Initial LogMAR VA (mean VA in decimal) | 0.18 ± 0.20 (0.16) | 0.58 ± 0.33 (0.26) | 1.16 ± 0.78 (0.07) | 0.278 | 0.012** | 0.119 |
Initial CMT (μm) | 260.40 ± 89.98 | 377.50 ± 85.25 | 490.20 ± 210.50 | 0.254 | 0.029** | 0.271 |